Molecular and Functional Characteristics of Glycerol Transporter in HCT-15 Cell Model

HCT-15细胞模型中甘油转运蛋白的分子和功能特征

基本信息

  • 批准号:
    18590149
  • 负责人:
  • 金额:
    $ 2.57万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

To clarify the molecular and functional characteristics of glycerol transporters, we conducted studies on a Na^+-dependent one in HCT-15 cells, particularly examining the effects on glycerol uptake of 1) cell differentiation induced by butyrate treatment and 2) several compounds structurally analogous to glycerol.Butyrate treatment brought about an approximately 5-fold increase in the maximum glycerol transport rate, without altering the Michaelis constant (affinity) significantly. Glycerol uptake in butyrate-treated cells was highly Na^+-dependent and specifically inhibited by some structurally analogous compounds as it was in untreated cells, indicating an induction of the Na^+-dependent glycerol transporter. Furthermore, this induction was almost completely suppressed by actinomycin D, an inhibitor of gene transcription, and cycloheximide, an inhibitor of protein synthesis. All these findings provide evidences for the presence of a specific transporter protein for glycerol.Among sev … More eral compounds tested for their inhibitory effects on glycerol uptake, monoacetin and monobutyrin, which are ester type of glycerol derivatives, were found to be the most potent inhibitors. Because they inhibited glycerol uptake competitively, they may possibly be substrates of the glycerol transporter. This would suggest that glycerol ester derivatives of drugs might be delivered via the transporter. Interestingly, enantioselective characteristic was found for competitive inhibition, though relatively weak, by 1, 2-propanediol, where the S-(+)-enantiomer is favored by the transporter than the R-(-)-enantiomer. All these features are also characteristic of transport mediated by a specific transporter protein, providing additional evidences for the presence of such a specific transporter protein for glycerol.Thus, we could obtain several lines of evidences for the presence of a Na^+-dependent glycerol transporter in HCT-15 cells. This would help in identifying it and elucidating its transport mechanism and physiological role. Less
为了阐明甘油转运蛋白的分子和功能特征,我们对 HCT-15 细胞中的 Na^+ 依赖性甘油转运蛋白进行了研究,特别检查了 1)丁酸盐处理诱导的细胞分化和 2)结构上的几种化合物对甘油摄取的影响。与甘油类似。丁酸盐处理使最大甘油转运速率增加约 5 倍,而不会显着改变丁酸盐处理的甘油摄取。细胞是高度Na^+依赖性的,并且与未处理的细胞中一样被一些结构类似的化合物特异性抑制,表明Na^+依赖性甘油转运蛋白的诱导。此外,这种诱导几乎完全被放线菌素D(一种抑制剂)抑制。基因转录的抑制剂和蛋白质合成抑制剂放线菌酮,所有这些发现都为甘油的特定转运蛋白的存在提供了证据。在七种化合物中测试了其对甘油的抑制作用。甘油摄取,甘油衍生物的酯型单醋精和单丁酸甘油酯被发现是最有效的抑制剂,因为它们竞争性地抑制甘油摄取,因此它们可能是甘油转运蛋白的底物。不同意可能是通过转运蛋白传递的,但发现 1, 2-丙二醇具有竞争性抑制作用,尽管相对较弱,其中S-(+)-对映异构体比 R-(-)-对映异构体更受转运蛋白青睐。所有这些特征也是特定转运蛋白介导的转运的特征,为甘油的这种特定转运蛋白的存在提供了证据。因此,我们可以获得 HCT-15 细胞中存在 Na^+ 依赖性甘油转运蛋白的多种证据,这将有助于识别它并阐明其转运机制和生理作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HCT-15細胞におけるNa÷依存性glycerQl担体輸送系の機能特性と制御機構
HCT-15细胞Na+依赖性甘油Ql载体转运系统的功能特征及调控机制
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    藤本 菜未; 他
  • 通讯作者:
Enhanced Uptake of Glycerol by Butyrate Treatment in HCT-15 Human Colon Cancer Cell Line
丁酸盐处理增强 HCT-15 人结肠癌细胞系对甘油的吸收
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujimoto; N.; et. al.
  • 通讯作者:
    et. al.
Effect of Glycerol-Related Compounds on Carrier-Mediated Glycerol Uptake in HCT-15 Human Colon Cancer Cell Line
甘油相关化合物对 HCT-15 人结肠癌细胞系中载体介导的甘油摄取的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujimoto; N.; et. al.
  • 通讯作者:
    et. al.
Enhanced Uptake of Glycerol by Butyrate Treatment in HCT-15 Human Colon Cancer Cell Line
丁酸盐处理增强 HCT-15 人结肠癌细胞系对甘油的吸收
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujimoto; N. et al.
  • 通讯作者:
    N. et al.
Functional Characters and Regulation Mechanism of the Nat-Dependent Carrier-Mediated Glycerol Transport System in HCT-15 Cells
HCT-15细胞中Nat依赖性载体介导的甘油转运系统的功能特征和调控机制
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fujimoto; N.; et. al.
  • 通讯作者:
    et. al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YUASA Hiroaki其他文献

YUASA Hiroaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YUASA Hiroaki', 18)}}的其他基金

Functional Characteristics of a Novel Transporter Specifically Expressed in the Endoplasmic Reticulum in Dendritic Cells and its Role in Immune System
树突状细胞内质网特异性表达的新型转运蛋白的功能特性及其在免疫系统中的作用
  • 批准号:
    23659085
  • 财政年份:
    2011
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification and Functional Analysis of the Na^+-Dependent Glycerol Transporter in HCT-15 Cells
HCT-15 细胞中 Na^-依赖性甘油转运蛋白的鉴定和功能分析
  • 批准号:
    20590151
  • 财政年份:
    2008
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pharmacokinetic and Cellular Biological Study on Colonic Absorption : Strategies for Optimized Controlled Release Oral Drug Delivery
结肠吸收的药代动力学和细胞生物学研究:优化控释口服药物递送策略
  • 批准号:
    12672155
  • 财政年份:
    2000
  • 资助金额:
    $ 2.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

From single molecule to microfluidic 3D tissue platforms: novel multiscale tools to investigate hyper-stimulated immune cells in the circulation
从单分子到微流体 3D 组织平台:研究循环中过度刺激免疫细胞的新型多尺度工具
  • 批准号:
    10358578
  • 财政年份:
    2018
  • 资助金额:
    $ 2.57万
  • 项目类别:
Circumventing the Blood-Testis Barrier
绕过血睾屏障
  • 批准号:
    9329790
  • 财政年份:
    2017
  • 资助金额:
    $ 2.57万
  • 项目类别:
Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer
3-deazaneplanocin A 和吉西他滨治疗胰腺癌的表观遗传学治疗
  • 批准号:
    8177487
  • 财政年份:
    2011
  • 资助金额:
    $ 2.57万
  • 项目类别:
Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer
3-deazaneplanocin A 和吉西他滨治疗胰腺癌的表观遗传学治疗
  • 批准号:
    8311608
  • 财政年份:
    2011
  • 资助金额:
    $ 2.57万
  • 项目类别:
Proteomic Evaluation of the Blood-Brain Barrier Receptor-Mediated Transportome
血脑屏障受体介导的转运组的蛋白质组学评估
  • 批准号:
    8471795
  • 财政年份:
    2010
  • 资助金额:
    $ 2.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了